Skip to content
Recall Observatory FDA recall evidence

Drug product

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21

D-0520-2017

February 03, 2017

Class II

Product summary

Firm
Amerisource Health Services
Event
Event 76636
Status
Terminated
Classification
Class II
Quantity
19,393 cartons (581,790 extended release tablets)
Official record key
drug-enforcement:D-0520-2017

Official wording

Reason: Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

Code information: Lot #160133, 160549 Exp. 08/17 Lot #162006; Exp. 09/17 Lot #163348A, 163348B; Exp. 10/17

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications